The healthcare sector saw $450B in M&A deal value in 2025, and 2026 is on track to exceed that. This report breaks down where the smart money is going.
Key Findings
- AI-enabled biotech platforms commanding 3x valuation premiums over traditional discovery models
- Health-tech convergence creating new acquisition categories at the intersection of SaaS and care delivery
- Private equity increasing healthcare exposure: 28% of all healthcare M&A now PE-backed
- Cross-border deals resurging as regulatory frameworks harmonize
